260 related articles for article (PubMed ID: 24747071)
1. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.
Said EA; Al-Yafei F; Zadjali F; Hasson SS; Al-Balushi MS; Al-Mahruqi S; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
Immunol Lett; 2014 Jul; 160(1):58-64. PubMed ID: 24747071
[TBL] [Abstract][Full Text] [Related]
2. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression.
Soriano-Sarabia N; Vallejo A; Ramírez-Lorca R; Rodríguez Mdel M; Salinas A; Pulido I; Sáez ME; Leal M
J Acquir Immune Defic Syndr; 2008 Oct; 49(2):128-35. PubMed ID: 18769358
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in Toll-Like Receptors (TLRs)-7 and
Shaikh N; Nirmalkar A; Thakar M
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):577-582. PubMed ID: 30793925
[TBL] [Abstract][Full Text] [Related]
4. TLR7 Polymorphism (rs179008 and rs179009) in HIV-Infected Individual Naïve to ART.
Singh H; Samani D; Aggarwal S
Mediators Inflamm; 2020; 2020():6702169. PubMed ID: 32565728
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy.
Vallejo A; Molina-Pinelo S; de Felipe B; Abad-Fernández M; González-Escribano MF; Leal M; Soriano-Sarabia N
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):252-256. PubMed ID: 32658127
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.
Bochud PY; Hersberger M; Taffé P; Bochud M; Stein CM; Rodrigues SD; Calandra T; Francioli P; Telenti A; Speck RF; Aderem A;
AIDS; 2007 Feb; 21(4):441-6. PubMed ID: 17301562
[TBL] [Abstract][Full Text] [Related]
7. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.
Oh DY; Baumann K; Hamouda O; Eckert JK; Neumann K; Kücherer C; Bartmeyer B; Poggensee G; Oh N; Pruss A; Jessen H; Schumann RR
AIDS; 2009 Jan; 23(3):297-307. PubMed ID: 19114863
[TBL] [Abstract][Full Text] [Related]
8. Frequency of TLR4 (1063A/G and 1363C/T) polymorphisms in healthy and HIV-infected Omani individuals and their relationship to viral load and T cell count.
Said EA; Al-Yafei F; Zadjali F; Al-Balushi MS; Hasson SS; Al-Mahroqi SH; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173197
[TBL] [Abstract][Full Text] [Related]
9. An assessment of toll-like receptor 7 and 8 gene polymorphisms with susceptibility to HIV-1 infection, AIDS development and response to antiretroviral therapy.
Zaidane I; Ouladlahsen A; Bensghir R; Chihab H; Jadid FZ; Fɩhry RE; Baba H; Filali KME; Oudghiri M; Wakrim L; Benjelloun S; Ezzikouri S
Immunol Lett; 2020 Nov; 227():88-95. PubMed ID: 32888973
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.
Pine SO; McElrath MJ; Bochud PY
AIDS; 2009 Nov; 23(18):2387-95. PubMed ID: 19855253
[TBL] [Abstract][Full Text] [Related]
11. TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients.
Joshi A; Punke EB; Mehmetoglu-Gurbuz T; Peralta DP; Garg H
BMC Infect Dis; 2019 Jan; 19(1):56. PubMed ID: 30651082
[TBL] [Abstract][Full Text] [Related]
12. Impact of TLR7 and TLR9 polymorphisms on susceptibility to placental infections and pregnancy complications.
Sánchez-Luquez K; Schadock IC; Gonçalves CV; Tornatore M; Finger-Jardim F; Avila EC; Soares MA; de Martínez AMB; Ellwanger JH; Chies JAB; da Hora VP
J Reprod Immunol; 2021 Aug; 146():103342. PubMed ID: 34102513
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever.
Arslan S; Engin A; Özbilüm N; Bakır M
J Med Virol; 2015 Jul; 87(7):1090-5. PubMed ID: 25879168
[TBL] [Abstract][Full Text] [Related]
14. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Toll-Like Receptor 7, 9, and 10 Polymorphisms and the Severity of Coronavirus Disease 2019.
Bayyurt B; Baltacı S; Şahin NÖ; Arslan S; Bakır M
Jpn J Infect Dis; 2024 May; 77(3):161-168. PubMed ID: 38296538
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children.
Freguja R; Gianesin K; Del Bianco P; Malacrida S; Rampon O; Zanchetta M; Giaquinto C; De Rossi A
AIDS; 2012 Mar; 26(6):765-8. PubMed ID: 22269973
[TBL] [Abstract][Full Text] [Related]
18. The
Jabłońska A; Jabłonowska E; Studzińska M; Kamerys J; Paradowska E
Cells; 2021 Sep; 10(9):. PubMed ID: 34572011
[TBL] [Abstract][Full Text] [Related]
19. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.
Inoue N; Katsumata Y; Watanabe M; Ishido N; Manabe Y; Watanabe A; Masutani R; Hidaka Y; Iwatani Y
Autoimmunity; 2017 May; 50(3):182-191. PubMed ID: 28013570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
